Matthew Johnson is an accomplished pharmaceutical commercialization and specialty provider services executive with 25+ years of experience. He is the former COO/GM at ASD Healthcare; former VP Strategy and M&A at AmerisourceBergen Specialty Group; and has served on the Board of Novologix, which was sold to CVS/Caremark. He is currently the Managing Partner at Ingenium Global, a pharma commercialization consulting and private equity investment firm.